Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
Clinical trial NCT07259928 · RECRUITING
Trial details
- NCT number
- NCT07259928
- Sponsor
- Annexin Pharmaceuticals AB
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2026-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.